EMA highlights achievements at management board meeting

8 October 2016

New vice chairman elected

At its October 6, 2016 meeting in London, the European Medicines Agency’s management board elected Grzegorz Cessak as vice chairman for a three-year period. Dr Cessak is president of Poland’s Office for registration of Medicinal Products, Medical Devices and Biocidal Products, a post he has held since July 2009. He has served as a member of EMA’s management board since January 2010. Dr Cessak steps into the role that was vacated by Christa Wirthumer-Hoche following her election as chairperson at the March 2016 management board meeting.

Mid-year report: launch of PRIME is a success

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK